Skip to main content Back to Top
Advertisement

10/4/2019

Loxapine Tablets

Products Affected - Description

    • Loxapine oral tablet, Lannett, 10 mg, bottle, tablet 100 count, NDC 00527-1395-01
    • Loxapine oral tablet, Lannett, 25 mg, bottle, tablet 100 count, NDC 00527-1396-01
    • Loxapine oral tablet, Lannett, 5 mg, bottle, tablet 100 count, NDC 00527-1394-01
    • Loxapine oral tablet, Lannett, 50 mg, bottle, tablet 100 count, NDC 00527-1397-01
    • Loxapine oral tablet, Marlex, 10 mg, bottle, tablet 100 count, NDC 10135-0586-01
    • Loxapine oral tablet, Marlex, 25 mg, bottle, tablet 100 count, NDC 10135-0587-01
    • Loxapine oral tablet, Marlex, 5 mg, bottle, tablet 100 count, NDC 10135-0585-01
    • Loxapine oral tablet, Marlex, 50 mg, bottle, tablet 100 count, NDC 10135-0588-01
    • Loxapine oral tablet, Mylan Institutional, 10 mg, bottle, tablet 100 count, NDC 00378-7010-01
    • Loxapine oral tablet, Mylan Institutional, 25 mg, bottle, tablet 100 count, NDC 00378-7025-01
    • Loxapine oral tablet, Mylan Institutional, 5 mg, bottle, tablet 100 count, NDC 00378-7005-01
    • Loxapine oral tablet, Mylan Institutional, 50 mg, bottle, tablet 100 count, NDC 00378-7050-01
    • Loxapine oral tablet, Teva, 10 mg, bottle, tablet 100 count, NDC 00591-0370-01 - discontinued
    • Loxapine oral tablet, Teva, 5 mg, bottle, tablet 100 count, NDC 00591-0369-01

Reason for the Shortage

    • TEVA has loxapine tablets on shortage and did not provide a reason. The company discontinued loxapine 10 mg tablets in September 2019.
    • Marlex has loxapine tablets on shortage and did not provide a reason.
    • Lannett has loxapine tablets on shortage due to manufacturing delays.
    • Mylan Institutional has loxapine tablets on shortage and did not provide a reason.

Available Products

    • Loxapine oral tablet, Teva, 25 mg, bottle, tablet 100 count, NDC 00591-0371-01
    • Loxapine oral tablet, Teva, 50 mg, bottle, tablet 100 count, NDC 00591-0372-01

Estimated Resupply Dates

    • TEVA has loxapine 5 mg tablets on back order and the company estimates a release date of early-November 2019.
    • Marlex has loxapine 5 mg, 10 mg, 25 mg, and 50 mg tablets on back order and the company cannot estimate a release date.
    • Lannett has loxapine 5 mg on backorder and the company estimates a release date of February 2020. The 10 mg, 25 mg, and 50 mg tablets are also on back order and the company cannot estimate a release date.
    • Mylan Institutional has loxapine 5 mg, 10 mg, 25 mg, and 50 mg tablets on back order and the company estimates a release date of late-January 2020.

Updated

Updated October 4, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Created September 12, 2019 by Rachael Freeman, PharmD, BCPS. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins